(Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 8.09%24.29B | -6.94%101.7B | -9.85%72.77B | -13.33%47.84B | -24.20%22.47B | -12.11%109.29B | -17.48%80.72B | -10.51%55.19B | 2.56%29.64B | 47.09%124.35B |
Operating income | 8.09%24.29B | -6.94%101.7B | -9.85%72.77B | -13.33%47.84B | -24.20%22.47B | -12.11%109.29B | -17.48%80.72B | -10.51%55.19B | 2.56%29.64B | 47.09%124.35B |
Operating expenses | -10.06%-23.04B | 7.08%-95.89B | 9.59%-68.37B | 13.39%-44.86B | 24.97%-20.93B | 13.08%-103.2B | 19.27%-75.62B | 12.00%-51.79B | -1.11%-27.9B | -49.15%-118.72B |
Gross profit | -18.72%1.25B | -4.64%5.81B | -13.69%4.4B | -12.37%2.98B | -11.83%1.54B | 8.32%6.1B | 23.00%5.1B | 20.49%3.4B | 32.91%1.75B | 13.91%5.63B |
Selling expenses | -4.51%-250.95M | -0.86%-1.08B | 3.91%-766.25M | 5.60%-503.03M | -1.00%-240.12M | -9.58%-1.07B | -14.85%-797.4M | -14.53%-532.87M | -11.36%-237.75M | -20.73%-973.49M |
Administrative expenses | 5.14%-693.84M | 0.43%-3.38B | 2.87%-2.38B | 0.52%-1.58B | 0.48%-731.41M | -8.56%-3.39B | -15.13%-2.45B | -13.52%-1.59B | -21.06%-734.93M | -14.30%-3.13B |
Research and development expenses | 8.95%-26.49M | -18.89%-233.19M | -34.05%-142.45M | 47.10%-25.88M | -15.93%-29.1M | -14.30%-196.14M | -9.97%-106.26M | 25.90%-48.92M | -27.39%-25.1M | -15.01%-171.6M |
Profit from asset sales | -258.56%-851.87K | -4.93%186.26M | 1,529.95%147.64M | 847.37%61.99M | -65.85%537.24K | 67.46%195.91M | -91.56%9.06M | -85.47%6.54M | -54.03%1.57M | 234.13%116.99M |
Revaluation surplus | -81.27%-14.95M | 354.32%266.88M | 46.78%-49.77M | 64.93%-27.29M | 86.24%-8.25M | -201.71%-104.94M | -209.39%-93.53M | -146.28%-77.82M | -73,707.01%-59.95M | -13.51%-34.78M |
-Changes in the fair value of other assets | -81.27%-14.95M | 354.32%266.88M | 46.78%-49.77M | 64.93%-27.29M | 86.24%-8.25M | -201.71%-104.94M | -209.39%-93.53M | -146.28%-77.82M | -73,707.01%-59.95M | -13.51%-34.78M |
Impairment and provision | -31.24%-50.59M | -144.36%-351.89M | 1.18%-85.4M | 20.14%-45.37M | -170.53%-38.55M | 58.81%-144M | -402.03%-86.41M | -1,865.36%-56.82M | 379.05%54.65M | -90.36%-349.63M |
-Other impairment is provision | -31.24%-50.59M | -144.36%-351.89M | 1.18%-85.4M | 20.14%-45.37M | -170.53%-38.55M | 58.81%-144M | -402.03%-86.41M | -1,865.36%-56.82M | 379.05%54.65M | -90.36%-349.63M |
Special items of operating profit | 1.24%955.9M | 17.49%4.78B | 12.25%3.35B | 5.79%2.11B | 43.34%944.17M | -7.53%4.07B | 1.53%2.98B | 6.22%2B | -5.53%658.67M | 41.43%4.4B |
Operating profit | -19.86%1.1B | 10.29%5.73B | -2.00%4.29B | -3.92%2.85B | 2.45%1.37B | -1.32%5.2B | 4.47%4.37B | 3.21%2.97B | 21.36%1.34B | 31.52%5.27B |
Financing cost | 46.91%-84.59M | -613.77%-259.08M | -232.51%-190M | -188.98%-42.33M | -9.12%-159.33M | 112.62%50.43M | 155.65%143.38M | 126.97%47.57M | -118.35%-146.02M | 36.09%-399.56M |
Special items of earning before tax | -81.76%2.61M | 928.87%36.8M | 142.29%28.27M | 150.78%7.43M | 5.70%14.31M | 96.71%-4.44M | 109.66%11.67M | -651.21%-14.62M | 222.91%13.54M | -186.44%-135.01M |
Earning before tax | -17.07%1.02B | 5.09%5.51B | -8.93%4.12B | -6.14%2.82B | 1.68%1.23B | 10.80%5.24B | 18.93%4.53B | 11.06%3B | 15.94%1.21B | 33.85%4.73B |
Tax | 23.00%-175.63M | -9.30%-1.06B | -9.17%-825.92M | 3.63%-533.17M | -9.08%-228.08M | -21.01%-967.54M | -31.52%-756.56M | -22.85%-553.25M | -17.75%-209.09M | -20.57%-799.56M |
After-tax profit from continuing operations | -15.72%842.3M | 4.13%4.45B | -12.56%3.3B | -6.70%2.28B | 0.13%999.42M | 8.72%4.28B | 16.69%3.77B | 8.71%2.45B | 15.57%998.14M | 36.91%3.93B |
Earning after tax | -15.72%842.3M | 4.13%4.45B | -12.56%3.3B | -6.70%2.28B | 0.13%999.42M | 8.72%4.28B | 16.69%3.77B | 8.71%2.45B | 15.57%998.14M | 36.91%3.93B |
Minority profit | -8.48%39.56M | 17.33%230.85M | -31.10%134.25M | -6.27%112.84M | 178.34%43.23M | -10.29%196.75M | 27.44%194.84M | 33.83%120.39M | -46.10%15.53M | 85.72%219.32M |
Profit attributable to shareholders | -16.05%802.73M | 3.50%4.22B | -11.55%3.16B | -6.73%2.17B | -2.69%956.19M | 9.85%4.08B | 16.15%3.58B | 7.66%2.33B | 17.70%982.61M | 34.82%3.71B |
Basic earnings per share | -15.38%0.11 | 5.01%0.5827 | -11.01%0.4301 | -3.23%0.3 | 0.00%0.13 | 10.98%0.5549 | 15.07%0.4833 | 6.90%0.31 | 18.18%0.13 | 35.14%0.5 |
Diluted earnings per share | -15.38%0.11 | 4.92%0.5822 | -11.01%0.4301 | -3.23%0.3 | 0.00%0.13 | 10.98%0.5549 | 15.07%0.4833 | 6.90%0.31 | 18.18%0.13 | 35.14%0.5 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
Auditor | -- | Shinnaganaka & Chung Certified Public Accountants (Special General Partnership) | -- | -- | -- | Shinnaganaka & Chung Certified Public Accountants (Special General Partnership) | -- | -- | -- | Shinnaganaka & Chung Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data